G
-
Vetter prepares for further growth
As part of its business growth strategy, Vetter has announced that a triple-digit million euro syndicated loan has been arranged with a consortium of banks led by Deutsche Bank AG, the Landesbank Baden-Württemberg, and Commerzbank AG.
G | 25 May 2012
-
New pulmonary embolism treatments offer patients freedom from needles
Treatments for pulmonary embolisms (PE) will evolve to better suit patient needs and enhance their quality of life, according to a report by GlobalData.
G | 24 May 2012
-
Global generic drug markets will grow to US$221 billion by 2016
Driven by the need to control costs, the use of generic drugs has grown considerably in recent years, even in markets where traditionally they have not been favored.
G | 23 May 2012
-
Burgopak launch Chrysalis Carton in partnership with Medica Packaging
The solution connects the outer carton and patient information leaflet (PIL) conveniently together. The patient pulls a perforated flap on the carton to expose the patient leaflet, which they can unfold to display the product information.
G | 21 May 2012
-
US Supreme Court clears way for generic patent challenges
After the ruling, generic manufacturers will now be able to challenge the content of patent descriptions and, if successful, ultimately force approval of the ANDA. Writing for the Court in a unanimous decision, Justice Elena Kagan chastised the FDA for using ambiguous or opaque guidelines and forms that lend to the confusion surrounding patent decisions.
G | 18 May 2012
-
Pharmaceutical giants set to lose dominance in urological disorders market
Major pharmaceutical companies are predicted to lose their footing in the urological disorders market by 2017, a report by GBI Research has found.
G | 17 May 2012
-
Labor L+S AG, Symbiosis form alliance
Labor L+S AG, Bad Bocklet and Symbiosis, the newly created business division of Biopharm GmbH, Heidelberg, announced that they have entered into an exclusive business alliance.
G | 16 May 2012
-
ACM Global Central Laboratory establishes Mumbai-based subsidiary
ACM Global Central Lab has advanced its hybrid central lab model in Mumbai with an operational facility dedicated to manage clinical trials testing in India and provide study support throughout Asia Pacific.
G | 15 May 2012
-
Siro Clinpharm appoints chief executive officer
Siro Clinpharm announced the appointment of Gopakumar Menon as chief executive officer.
G | 09 May 2012
-
Kuehne + Nagel launches innovative airfreight solution for pharmaceutical products
KN PharmaChain offers – among other features – door-to-door temperature control, a 24 hour alert system, optional wireless temperature measuring and best practice (GxP) standards for facilities, working processes and training programmes.
G | 08 May 2012
